Bolt Biotherapeutics, Inc. (BOLT) Total liabilities 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) total liabilities at each fiscal year-end, per SEC filings.
$30.2MFY2025 · since FY2020: $46.2M → $30.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $30.2M | -28.7% |
| FY2024 | $42.4M | -9.8% |
| FY2023 | $47.0M | -16.4% |
| FY2022 | $56.3M | -2.3% |
| FY2021 | $57.6M | +24.7% |
| FY2020 | $46.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLT financial trends
BOLT RevenueBOLT Net incomeBOLT Net marginBOLT Gross profitBOLT Gross marginBOLT Operating incomeBOLT Operating marginBOLT Operating cash flowBOLT Free cash flowBOLT Capital expendituresBOLT Return on equityBOLT Stock buybacksBOLT Dividends paidBOLT Total assetsBOLT Shareholders’ equityBOLT overview →